TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND CRYSTALLIZATION INHIBITOR
The present invention relates to an inventive transdermal therapeutic system (TTS) comprising rotigotine, a pharmaceutically acceptable adhesive comprising styrene butadiene block copolymer and a crystallization inhibitor, an inventive matrix with an extended release of rotigotine suitable for a tra...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RYBACH, SIMON LANG, SUSANNE SAHR, FLORIAN FITZNER, ANSGAR |
| description | The present invention relates to an inventive transdermal therapeutic system (TTS) comprising rotigotine, a pharmaceutically acceptable adhesive comprising styrene butadiene block copolymer and a crystallization inhibitor, an inventive matrix with an extended release of rotigotine suitable for a transdermal therapeutic system, an inventive production method of a respective matrix or a respective TTS comprising rotigotine, as well as uses of the inventive matrix and the inventive TTS.
La présente invention concerne un système thérapeutique transdermique (TTS) inventif comprenant de la rotigotine, un adhésif pharmaceutiquement acceptable comprenant un copolymère à blocs de styrène-butadiène et un inhibiteur de cristallisation, une matrice inventive ayant une libération prolongée de rotigotine appropriée pour un système thérapeutique transdermique, un procédé de fabrication inventif d'une matrice respective ou d'un TTS respectif comprenant de la rotigotine, ainsi que des utilisations de la matrice inventive et du TTS inventif. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2013075823A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2013075823A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2013075823A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEsDqK-w4Gz0DaIXc80tgdNUi4nokspEifRQn1_7OADOPz8y7dULIw-VpYdtiCNZezsWchAvEaxDkxwHVMkXwMHoXrOW0BfgeFZYNvSDYWCB_INHUkCr9XiMTyntPl9pbYnK6bZpfHdp2kc7umVPv0lFFmus8O-LDTm-j_1BQn1MW0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND CRYSTALLIZATION INHIBITOR</title><source>esp@cenet</source><creator>RYBACH, SIMON ; LANG, SUSANNE ; SAHR, FLORIAN ; FITZNER, ANSGAR</creator><creatorcontrib>RYBACH, SIMON ; LANG, SUSANNE ; SAHR, FLORIAN ; FITZNER, ANSGAR</creatorcontrib><description>The present invention relates to an inventive transdermal therapeutic system (TTS) comprising rotigotine, a pharmaceutically acceptable adhesive comprising styrene butadiene block copolymer and a crystallization inhibitor, an inventive matrix with an extended release of rotigotine suitable for a transdermal therapeutic system, an inventive production method of a respective matrix or a respective TTS comprising rotigotine, as well as uses of the inventive matrix and the inventive TTS.
La présente invention concerne un système thérapeutique transdermique (TTS) inventif comprenant de la rotigotine, un adhésif pharmaceutiquement acceptable comprenant un copolymère à blocs de styrène-butadiène et un inhibiteur de cristallisation, une matrice inventive ayant une libération prolongée de rotigotine appropriée pour un système thérapeutique transdermique, un procédé de fabrication inventif d'une matrice respective ou d'un TTS respectif comprenant de la rotigotine, ainsi que des utilisations de la matrice inventive et du TTS inventif.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130530&DB=EPODOC&CC=WO&NR=2013075823A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130530&DB=EPODOC&CC=WO&NR=2013075823A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RYBACH, SIMON</creatorcontrib><creatorcontrib>LANG, SUSANNE</creatorcontrib><creatorcontrib>SAHR, FLORIAN</creatorcontrib><creatorcontrib>FITZNER, ANSGAR</creatorcontrib><title>TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND CRYSTALLIZATION INHIBITOR</title><description>The present invention relates to an inventive transdermal therapeutic system (TTS) comprising rotigotine, a pharmaceutically acceptable adhesive comprising styrene butadiene block copolymer and a crystallization inhibitor, an inventive matrix with an extended release of rotigotine suitable for a transdermal therapeutic system, an inventive production method of a respective matrix or a respective TTS comprising rotigotine, as well as uses of the inventive matrix and the inventive TTS.
La présente invention concerne un système thérapeutique transdermique (TTS) inventif comprenant de la rotigotine, un adhésif pharmaceutiquement acceptable comprenant un copolymère à blocs de styrène-butadiène et un inhibiteur de cristallisation, une matrice inventive ayant une libération prolongée de rotigotine appropriée pour un système thérapeutique transdermique, un procédé de fabrication inventif d'une matrice respective ou d'un TTS respectif comprenant de la rotigotine, ainsi que des utilisations de la matrice inventive et du TTS inventif.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEsDqK-w4Gz0DaIXc80tgdNUi4nokspEifRQn1_7OADOPz8y7dULIw-VpYdtiCNZezsWchAvEaxDkxwHVMkXwMHoXrOW0BfgeFZYNvSDYWCB_INHUkCr9XiMTyntPl9pbYnK6bZpfHdp2kc7umVPv0lFFmus8O-LDTm-j_1BQn1MW0</recordid><startdate>20130530</startdate><enddate>20130530</enddate><creator>RYBACH, SIMON</creator><creator>LANG, SUSANNE</creator><creator>SAHR, FLORIAN</creator><creator>FITZNER, ANSGAR</creator><scope>EVB</scope></search><sort><creationdate>20130530</creationdate><title>TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND CRYSTALLIZATION INHIBITOR</title><author>RYBACH, SIMON ; LANG, SUSANNE ; SAHR, FLORIAN ; FITZNER, ANSGAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2013075823A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RYBACH, SIMON</creatorcontrib><creatorcontrib>LANG, SUSANNE</creatorcontrib><creatorcontrib>SAHR, FLORIAN</creatorcontrib><creatorcontrib>FITZNER, ANSGAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RYBACH, SIMON</au><au>LANG, SUSANNE</au><au>SAHR, FLORIAN</au><au>FITZNER, ANSGAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND CRYSTALLIZATION INHIBITOR</title><date>2013-05-30</date><risdate>2013</risdate><abstract>The present invention relates to an inventive transdermal therapeutic system (TTS) comprising rotigotine, a pharmaceutically acceptable adhesive comprising styrene butadiene block copolymer and a crystallization inhibitor, an inventive matrix with an extended release of rotigotine suitable for a transdermal therapeutic system, an inventive production method of a respective matrix or a respective TTS comprising rotigotine, as well as uses of the inventive matrix and the inventive TTS.
La présente invention concerne un système thérapeutique transdermique (TTS) inventif comprenant de la rotigotine, un adhésif pharmaceutiquement acceptable comprenant un copolymère à blocs de styrène-butadiène et un inhibiteur de cristallisation, une matrice inventive ayant une libération prolongée de rotigotine appropriée pour un système thérapeutique transdermique, un procédé de fabrication inventif d'une matrice respective ou d'un TTS respectif comprenant de la rotigotine, ainsi que des utilisations de la matrice inventive et du TTS inventif.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2013075823A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND CRYSTALLIZATION INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A09%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RYBACH,%20SIMON&rft.date=2013-05-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2013075823A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |